Kindly MD, Inc.
NAKA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.30 | 0.00 | 0.00 |
| FCF Yield | -51.99% | -2.61% | -2.57% | 0.33% |
| EV / EBITDA | -122.30 | -722.66 | -405.92 | 7,868.99 |
| Quality | ||||
| ROIC | -99.84% | -306.88% | -348.82% | 16.02% |
| Gross Margin | 96.96% | -7.01% | -15.72% | 36.53% |
| Cash Conversion Ratio | 0.85 | 0.28 | 0.06 | 0.81 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.45% | 14.59% | 1,558,619.77% | 1,357,889.93% |
| Free Cash Flow Growth | -649.18% | -1.34% | -891.46% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.50 | -0.08 | -0.08 | 0.12 |
| Interest Coverage | -8.51 | -29.01 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 19.26 | 63.81 | 88.41 | 26.59 |
| Cash Conversion Cycle | -1,402.91 | -21.42 | -8.55 | 4.78 |